메뉴 건너뛰기




Volumn 95, Issue 6, 2013, Pages 1110-1119

Mechanisms of resistance to anti-angiogenesis therapies

Author keywords

Anti angiogenesis; Autophagy; Predictive markers; Resistance; Targeted therapies

Indexed keywords

ALPHA INTERFERON; ANGIOGENIC FACTOR; AXITINIB; BEVACIZUMAB; CABOZANTINIB; CARBOPLATIN; EVEROLIMUS; IMATINIB; LINIFANIB; MAMMALIAN TARGET OF RAPAMYCIN; PACLITAXEL; PAZOPANIB; PLACEBO; PROTEIN TYROSINE KINASE; SORAFENIB; SUNITINIB; TEMSIROLIMUS; TIVOZANIB; VANDETANIB; VASCULOTROPIN;

EID: 84877755368     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.03.002     Document Type: Review
Times cited : (111)

References (133)
  • 1
    • 77955255788 scopus 로고    scopus 로고
    • Molecular diversity of VEGF-A as a regulator of its biological activity
    • J. Woolard, H.S. Bevan, S.J. Harper, and D.O. Bates Molecular diversity of VEGF-A as a regulator of its biological activity Microcirculation 16 2009 572 592
    • (2009) Microcirculation , vol.16 , pp. 572-592
    • Woolard, J.1    Bevan, H.S.2    Harper, S.J.3    Bates, D.O.4
  • 2
    • 84858079914 scopus 로고    scopus 로고
    • PI3K/AKT/mTOR pathway in angiogenesis
    • J. Karar, and A. Maity PI3K/AKT/mTOR pathway in angiogenesis Front. Mol. Neurosci. 4 2011 51
    • (2011) Front. Mol. Neurosci. , vol.4 , pp. 51
    • Karar, J.1    Maity, A.2
  • 3
    • 33846879810 scopus 로고    scopus 로고
    • The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
    • W.G. Kaelin Jr. The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma Clin. Cancer Res. 13 2007 680s 684s
    • (2007) Clin. Cancer Res. , vol.13
    • Kaelin Jr., W.G.1
  • 4
    • 0034650744 scopus 로고    scopus 로고
    • Oncogenes and tumor angiogenesis: Differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts
    • J. Rak, Y. Mitsuhashi, C. Sheehan, A. Tamir, A. Vioria-Petit, J. Filmus, S.J. Mansour, N.G. Ahn, and R.S. Kerbel Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras transformed epithelial cells and fibroblasts Cancer Res. 60 2000 490 498 (Pubitemid 30070780)
    • (2000) Cancer Research , vol.60 , Issue.2 , pp. 490-498
    • Rak, J.1    Mitsuhashi, Y.2    Sheehan, C.3    Tamir, A.4    Viloria-Petit, A.5    Filmus, J.6    Mansour, S.J.7    Ahn, N.G.8    Kerbel, R.S.9
  • 5
    • 0028834638 scopus 로고
    • Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells
    • S. Grugel, G. Finkenzeller, K. Weindel, B. Barleon, and D. Marmé Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells J. Biol. Chem. 270 1995 25915 25919
    • (1995) J. Biol. Chem. , vol.270 , pp. 25915-25919
    • Grugel, S.1    Finkenzeller, G.2    Weindel, K.3    Barleon, B.4    Marmé, D.5
  • 6
    • 0032541029 scopus 로고    scopus 로고
    • P42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
    • DOI 10.1074/jbc.273.29.18165
    • J. Milanini, F. Vinals, J. Pouysségur, and G. Pagès p42/p44 MAP kinase module plays a key role in the transcriptional regulation of vascular endothelial growth factor gene in fibroblasts J. Biol. Chem. 273 1998 18165 18172 (Pubitemid 28334735)
    • (1998) Journal of Biological Chemistry , vol.273 , Issue.29 , pp. 18165-18172
    • Milanini, J.1    Vinals, F.2    Pouyssegur, J.3    Pages, G.4
  • 14
    • 13444278498 scopus 로고    scopus 로고
    • Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies
    • H.P. Gerber, and N. Ferrara Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies Cancer Res. 65 2005 671 680 (Pubitemid 40216420)
    • (2005) Cancer Research , vol.65 , Issue.3 , pp. 671-680
    • Gerber, H.-P.1    Ferrara, N.2
  • 16
    • 11844254414 scopus 로고    scopus 로고
    • Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
    • DOI 10.1126/science.1104819
    • R.K. Jain Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy Science 307 2005 58 62 (Pubitemid 40093472)
    • (2005) Science , vol.307 , Issue.5706 , pp. 58-62
    • Jain, R.K.1
  • 22
    • 77954754601 scopus 로고    scopus 로고
    • Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420
    • S.K. Williamson, J. Moon, C.H. Huang, P.P. Guaglianone, M. LeBlanc, G.T. Wolf, and S.G. Urba Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420 J. Clin. Oncol. 28 2010 3330 3335
    • (2010) J. Clin. Oncol. , vol.28 , pp. 3330-3335
    • Williamson, S.K.1    Moon, J.2    Huang, C.H.3    Guaglianone, P.P.4    Leblanc, M.5    Wolf, G.T.6    Urba, S.G.7
  • 31
    • 33746899015 scopus 로고    scopus 로고
    • Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway
    • DOI 10.1158/1541-7786.MCR-05-0234
    • N. Pore, Z. Jiang, H.K. Shu, E. Bernhard, G.D. Kao, and A. Maity Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway Mol. Cancer Res. 4 2006 471 479 (Pubitemid 44197042)
    • (2006) Molecular Cancer Research , vol.4 , Issue.7 , pp. 471-479
    • Pore, N.1    Jiang, Z.2    Shu, H.-K.3    Bernhard, E.4    Kao, G.D.5    Maity, A.6
  • 32
    • 0037111665 scopus 로고    scopus 로고
    • BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin
    • DOI 10.1182/blood-2002-01-0109
    • M. Mayerhofer, P. Valent, W.R. Sperr, J.D. Griffin, and C. Sillaber BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin Blood 100 2002 3767 3775 (Pubitemid 35303950)
    • (2002) Blood , vol.100 , Issue.10 , pp. 3767-3775
    • Mayerhofer, M.1    Valent, P.2    Sperr, W.R.3    Griffin, J.D.4    Sillaber, C.5
  • 33
    • 34548178582 scopus 로고    scopus 로고
    • The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells
    • DOI 10.1074/jbc.M700563200
    • O. Dormond, J.C. Madsen, and D.M. Briscoe The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells J. Biol. Chem. 282 2007 23679 23686 (Pubitemid 47311969)
    • (2007) Journal of Biological Chemistry , vol.282 , Issue.32 , pp. 23679-23686
    • Dormond, O.1    Madsen, J.C.2    Briscoe, D.M.3
  • 34
    • 0034654174 scopus 로고    scopus 로고
    • Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
    • H. Zhong, K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, M.M. Georgescu, J.W. Simons, and G.L. Semenza Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics Cancer Res. 60 2000 1541 1545 (Pubitemid 30183422)
    • (2000) Cancer Research , vol.60 , Issue.6 , pp. 1541-1545
    • Zhong, H.1    Chiles, K.2    Feldser, D.3    Laughner, E.4    Hanrahan, C.5    Georgescu, M.-M.6    Simons, J.W.7    Semenza, G.L.8
  • 36
    • 0035012605 scopus 로고    scopus 로고
    • HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
    • DOI 10.1128/MCB.21.12.3995-4004.2001
    • E. Laughner, P. Taghavi, K. Chiles, P.C. Mahon, and G.L. Semenza HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol. Cell. Biol. 21 2001 3995 4004 (Pubitemid 32476461)
    • (2001) Molecular and Cellular Biology , vol.21 , Issue.12 , pp. 3995-4004
    • Laughner, E.1    Taghavi, P.2    Chiles, K.3    Mahon, P.C.4    Semenza, G.L.5
  • 46
    • 77952300540 scopus 로고    scopus 로고
    • Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): Final analysis of overall survival
    • B. Escudier, J. Bellmunt, S. Negrier, E. Bajetta, B. Melichar, S. Bracarda, A. Ravaud, S. Golding, S. Jethwa, and V. Sneller Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival J. Clin. Oncol. 28 2010 2144 2150
    • (2010) J. Clin. Oncol. , vol.28 , pp. 2144-2150
    • Escudier, B.1    Bellmunt, J.2    Negrier, S.3    Bajetta, E.4    Melichar, B.5    Bracarda, S.6    Ravaud, A.7    Golding, S.8    Jethwa, S.9    Sneller, V.10
  • 47
    • 84857626952 scopus 로고    scopus 로고
    • Bevacizumab in the treatment of metastatic breast cancer: Friend or foe?
    • A.J. Montero, M. Escobar, G. Lopes, S. Gluck, and C. Vogel Bevacizumab in the treatment of metastatic breast cancer: friend or foe? Curr. Oncol. Rep. 14 2012 1 11
    • (2012) Curr. Oncol. Rep. , vol.14 , pp. 1-11
    • Montero, A.J.1    Escobar, M.2    Lopes, G.3    Gluck, S.4    Vogel, C.5
  • 50
    • 79551520348 scopus 로고    scopus 로고
    • Treatment-related mortality with bevacizumab in cancer patients: A meta-analysis
    • V. Ranpura, S. Hapani, and S. Wu Treatment-related mortality with bevacizumab in cancer patients: A meta-analysis J. Am. Med. Assoc. 305 2011 487 494
    • (2011) J. Am. Med. Assoc. , vol.305 , pp. 487-494
    • Ranpura, V.1    Hapani, S.2    Wu, S.3
  • 51
    • 43249095919 scopus 로고    scopus 로고
    • Tumor angiogenesis
    • DOI 10.1056/NEJMra0706596
    • R.S. Kerbel Tumor angiogenesis N. Engl. J. Med. 358 2008 2039 2049 (Pubitemid 351656458)
    • (2008) New England Journal of Medicine , vol.358 , Issue.19 , pp. 2039-2049
    • Kerbel, R.S.1
  • 54
    • 84861525048 scopus 로고    scopus 로고
    • Therapeutic targeting of BCR-ABL: Prognostic markers of response and resistance mechanism in chronic myeloid leukaemia
    • D.T. Yeung, and T.P. Hughes Therapeutic targeting of BCR-ABL: prognostic markers of response and resistance mechanism in chronic myeloid leukaemia Crit. Rev. Oncog. 17 2012 17 30
    • (2012) Crit. Rev. Oncog. , vol.17 , pp. 17-30
    • Yeung, D.T.1    Hughes, T.P.2
  • 55
    • 18844428327 scopus 로고    scopus 로고
    • Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
    • DOI 10.1016/j.cell.2005.02.034, PII S0092867405002370
    • A. Orimo, P.B. Gupta, D.C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A.L. Richardson, and R.A. Weinberg Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121 2005 335 348 (Pubitemid 40692295)
    • (2005) Cell , vol.121 , Issue.3 , pp. 335-348
    • Orimo, A.1    Gupta, P.B.2    Sgroi, D.C.3    Arenzana-Seisdedos, F.4    Delaunay, T.5    Naeem, R.6    Carey, V.J.7    Richardson, A.L.8    Weinberg, R.A.9
  • 56
    • 26644471951 scopus 로고    scopus 로고
    • Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
    • DOI 10.1016/j.ccr.2005.09.005, PII S1535610805002989
    • O. Casanovas, D.J. Hicklin, G. Bergers, and D. Hanahan Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors Cancer Cell 8 2005 299 309 (Pubitemid 41443415)
    • (2005) Cancer Cell , vol.8 , Issue.4 , pp. 299-309
    • Casanovas, O.1    Hicklin, D.J.2    Bergers, G.3    Hanahan, D.4
  • 57
    • 57849106330 scopus 로고    scopus 로고
    • PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment
    • Y. Crawford, I. Kasman, L. Yu, C. Zhong, X. Wu, Z. Modrusan, J. Kaminker, and N. Ferrara PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment Cancer Cell 15 2009 21 34
    • (2009) Cancer Cell , vol.15 , pp. 21-34
    • Crawford, Y.1    Kasman, I.2    Yu, L.3    Zhong, C.4    Wu, X.5    Modrusan, Z.6    Kaminker, J.7    Ferrara, N.8
  • 58
    • 79957921039 scopus 로고    scopus 로고
    • Growing tumor vessels: More than one way to skin a cat - Implications for angiogenesis targeted cancer therapies
    • R. Leite de Oliveira, A. Hamm, and M. Mazzone Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies Mol. Aspects Med. 32 2011 71 87
    • (2011) Mol. Aspects Med. , vol.32 , pp. 71-87
    • Leite De Oliveira, R.1    Hamm, A.2    Mazzone, M.3
  • 61
    • 33846821872 scopus 로고    scopus 로고
    • Targeted therapy for metastatic renal cell carcinoma
    • DOI 10.1200/JCO.2006.08.5415
    • R.J. Motzer, and R.M. Bukowski Targeted therapy for metastatic renal cell carcinoma J. Clin. Oncol. 24 2006 5601 5608 (Pubitemid 46631341)
    • (2006) Journal of Clinical Oncology , vol.24 , Issue.35 , pp. 5601-5608
    • Motzer, R.J.1    Bukowski, R.M.2
  • 64
    • 54549123309 scopus 로고    scopus 로고
    • VEGF-A splicing: The key to anti-angiogenic therapeutics?
    • S.J. Harper, and D.O. Bates VEGF-A splicing: The key to anti-angiogenic therapeutics? Nat. Rev. Cancer 8 2008 880 887
    • (2008) Nat. Rev. Cancer , vol.8 , pp. 880-887
    • Harper, S.J.1    Bates, D.O.2
  • 65
    • 0037098860 scopus 로고    scopus 로고
    • 165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma
    • D.O. Bates, T.G. Cui, J.M. Doughty, M. Winkler, M. Sugiono, J.D. Shields, D. Peat, D. Gillatt, and S.J. Harper VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma Cancer Res. 62 2002 4123 4131 (Pubitemid 34791084)
    • (2002) Cancer Research , vol.62 , Issue.14 , pp. 4123-4131
    • Bates, D.O.1    Cui, T.-G.2    Doughty, J.M.3    Winkler, M.4    Sugiono, M.5    Shields, J.D.6    Peat, D.7    Gillatt, D.8    Harper, S.J.9
  • 66
    • 42149152015 scopus 로고    scopus 로고
    • 165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: Balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
    • DOI 10.1038/sj.bjc.6604308, PII 6604308
    • A.H. Varey, E.S. Rennel, Y. Qiu, H.S. Bevan, R.M. Perrin, S. Raffy, A.R. Dixon, C. Paraskeva, O. Zaccheo, A.B. Hassan, S.J. Harper, and D.O. Bates VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy Br. J. Cancer 98 2008 1366 1379 (Pubitemid 351543576)
    • (2008) British Journal of Cancer , vol.98 , Issue.8 , pp. 1366-1379
    • Varey, A.H.R.1    Rennel, E.S.2    Qiu, Y.3    Bevan, H.S.4    Perrin, R.M.5    Raffy, S.6    Dixon, A.R.7    Paraskeva, C.8    Zaccheo, O.9    Hassan, A.B.10    Harper, S.J.11    Bates, D.O.12
  • 71
    • 58149456505 scopus 로고    scopus 로고
    • Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan
    • R.M. Zuniga, R. Torcuator, R. Jain, J. Anderson, T. Doyle, S. Ellika, L. Schultz, and T. Mikkelsen Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan J. Neurooncol. 91 2009 329 336
    • (2009) J. Neurooncol. , vol.91 , pp. 329-336
    • Zuniga, R.M.1    Torcuator, R.2    Jain, R.3    Anderson, J.4    Doyle, T.5    Ellika, S.6    Schultz, L.7    Mikkelsen, T.8
  • 72
    • 84862776792 scopus 로고    scopus 로고
    • HGF/c-Met pathway is one of the mediators of sunitinib-induced tumor cell type-dependent metastasis
    • F. Shojaei, B.H. Simmons, J.H. Lee, P.B. Lappin, and J.G. Christensen HGF/c-Met pathway is one of the mediators of sunitinib-induced tumor cell type-dependent metastasis Cancer Lett. 320 2012 48 55
    • (2012) Cancer Lett. , vol.320 , pp. 48-55
    • Shojaei, F.1    Simmons, B.H.2    Lee, J.H.3    Lappin, P.B.4    Christensen, J.G.5
  • 73
    • 34547107592 scopus 로고    scopus 로고
    • Hypoxia-driven selection of the metastatic phenotype
    • DOI 10.1007/s10555-007-9062-2, Special issue on Hypoxia and Cancer, Guest Editor: Gregg L. Semenza
    • R. Sullivan, and C.H. Graham Hypoxia-driven selection of the metastatic phenotype Cancer Metastasis Rev. 26 2007 319 331 (Pubitemid 47101665)
    • (2007) Cancer and Metastasis Reviews , vol.26 , Issue.2 , pp. 319-331
    • Sullivan, R.1    Graham, C.H.2
  • 75
    • 34247527730 scopus 로고    scopus 로고
    • Hypoxia-Inducible Factors, Stem Cells, and Cancer
    • DOI 10.1016/j.cell.2007.04.019, PII S0092867407005259
    • B. Keith, and M.C. Simon Hypoxia-inducible factors, stem cells, and cancer Cell 129 2007 465 472 (Pubitemid 46660978)
    • (2007) Cell , vol.129 , Issue.3 , pp. 465-472
    • Keith, B.1    Simon, M.C.2
  • 77
    • 60649087564 scopus 로고    scopus 로고
    • Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis
    • J.M. Ebos, C.R. Lee, W. Cruz-Munoz, G.A. Bjarnason, J.G. Christensen, and R.S. Kerbel Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis Cancer Cell 15 2009 232 239
    • (2009) Cancer Cell , vol.15 , pp. 232-239
    • Ebos, J.M.1    Lee, C.R.2    Cruz-Munoz, W.3    Bjarnason, G.A.4    Christensen, J.G.5    Kerbel, R.S.6
  • 78
    • 77956503727 scopus 로고    scopus 로고
    • Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres
    • E.E. Bar, A. Lin, V. Mahairaki, W. Matsui, and C.G. Eberhart Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres Am. J. Pathol. 177 2010 1491 1502
    • (2010) Am. J. Pathol. , vol.177 , pp. 1491-1502
    • Bar, E.E.1    Lin, A.2    Mahairaki, V.3    Matsui, W.4    Eberhart, C.G.5
  • 80
    • 84859385707 scopus 로고    scopus 로고
    • Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma
    • Y.L. Hu, M. DeLay, A. Jahangiri, A.M. Molinaro, S.D. Rose, W.S. Carbonell, and M.K. Aghi Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma Cancer Res. 72 2012 1773 1783
    • (2012) Cancer Res. , vol.72 , pp. 1773-1783
    • Hu, Y.L.1    Delay, M.2    Jahangiri, A.3    Molinaro, A.M.4    Rose, S.D.5    Carbonell, W.S.6    Aghi, M.K.7
  • 83
    • 0026485002 scopus 로고
    • Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
    • D. Shweiki, A. Itin, D. Soffer, and E. Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843 945
    • (1992) Nature , vol.359 , pp. 843-945
    • Shweiki, D.1    Itin, A.2    Soffer, D.3    Keshet, E.4
  • 85
    • 33645504221 scopus 로고    scopus 로고
    • Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells
    • M. Calvani, A. Rapisarda, B. Uranchimeg, R.H. Shoemaker, and G. Melillo Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells Blood 107 2006 2705 2712
    • (2006) Blood , vol.107 , pp. 2705-2712
    • Calvani, M.1    Rapisarda, A.2    Uranchimeg, B.3    Shoemaker, R.H.4    Melillo, G.5
  • 86
    • 33744959141 scopus 로고    scopus 로고
    • Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1
    • DOI 10.1074/jbc.M602003200
    • H. Okuyama, B. Krishnamachary, Y.F. Zhou, H. Nagasawa, M. Bosch-Marce, and G.L. Semenza Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1 J. Biol. Chem. 281 2006 15554 15563 (Pubitemid 43855148)
    • (2006) Journal of Biological Chemistry , vol.281 , Issue.22 , pp. 15554-15563
    • Okuyama, H.1    Krishnamachary, B.2    Zhou, Y.F.3    Nagasawa, H.4    Bosch-Marce, M.5    Semenza, G.L.6
  • 89
    • 0036831559 scopus 로고    scopus 로고
    • Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy?
    • DOI 10.1038/nrc925
    • S. Rafii, D. Lyden, R. Benezra, K. Hattori, and B. Heissig Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat. Rev. Cancer 2 2002 826 835 (Pubitemid 37328901)
    • (2002) Nature Reviews Cancer , vol.2 , Issue.11 , pp. 826-835
    • Rafii, S.1    Lyden, D.2    Benezra, R.3    Hattori, K.4    Heissig, B.5
  • 90
    • 4644295385 scopus 로고    scopus 로고
    • Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells
    • DOI 10.1182/blood-2004-01-0336
    • I. Rajantie, M. Ilmonen, A. Alminaite, U. Ozerdem, K. Alitalo, and P. Salven Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells Blood 104 2004 2084 2086 (Pubitemid 39297861)
    • (2004) Blood , vol.104 , Issue.7 , pp. 2084-2086
    • Rajantie, I.1    Ilmonen, M.2    Alminaite, A.3    Ozerdem, U.4    Alitalo, K.5    Salven, P.6
  • 91
    • 28444451122 scopus 로고    scopus 로고
    • Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors
    • DOI 10.1016/j.ymthe.2005.07.693, PII S1525001605014310
    • M. Aghi, and E.A. Chiocca Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors Mol. Ther. 12 2005 994 1005 (Pubitemid 41723033)
    • (2005) Molecular Therapy , vol.12 , Issue.6 , pp. 994-1005
    • Aghi, M.1    Chiocca, E.A.2
  • 92
    • 26944437515 scopus 로고    scopus 로고
    • + perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival
    • DOI 10.1038/ncb1288, PII N1288
    • S. Song, A.J. Ewald, W. Stallcup, Z. Werb, and G. Bergers PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival Nat. Cell Biol. 7 2005 870 879 (Pubitemid 41486287)
    • (2005) Nature Cell Biology , vol.7 , Issue.9 , pp. 870-879
    • Song, S.1    Ewald, A.J.2    Stallcup, W.3    Werb, Z.4    Bergers, G.5
  • 93
    • 24944587964 scopus 로고    scopus 로고
    • Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors
    • DOI 10.1016/j.ccr.2005.08.002, PII S1535610805002606
    • M. De Palma, M.A. Venneri, R. Galli, L. Sergi Sergi, L.S. Politi, M. Sampaolesi, and L. Naldini Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors Cancer Cell 8 2005 211 226 (Pubitemid 41317592)
    • (2005) Cancer Cell , vol.8 , Issue.3 , pp. 211-226
    • De Palma, M.1    Venneri, M.A.2    Galli, R.3    Sergi, L.S.4    Politi, L.S.5    Sampaolesi, M.6    Naldini, L.7
  • 94
  • 96
    • 19944422751 scopus 로고    scopus 로고
    • Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases
    • DOI 10.1016/j.ccr.2004.10.011, PII S1535610804003058
    • F. Winkler, S.V. Kozin, R.T. Tong, S.S. Chae, M.F. Booth, I. Garkavtsev, L. Xu, D.J. Hicklin, D. Fukumura, E. di Tomaso, L.L. Munn, and R.K. Jain Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases Cancer Cell 6 2004 553 563 (Pubitemid 40017699)
    • (2004) Cancer Cell , vol.6 , Issue.6 , pp. 553-563
    • Winkler, F.1    Kozin, S.V.2    Tong, R.T.3    Chae, S.-S.4    Booth, M.F.5    Garkavtsev, I.6    Xu, L.7    Hicklin, D.J.8    Fukumura, D.9    Di Tomaso, E.10    Munn, L.L.11    Jain, R.K.12
  • 98
    • 39849102836 scopus 로고    scopus 로고
    • HIF1alpha Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
    • DOI 10.1016/j.ccr.2008.01.034, PII S153561080800041X
    • R. Du, K.V. Lu, C. Petritsch, P. Liu, R. Ganss, E. Passegue, H. Song, S. Vandenberg, R.S. Johnson, Z. Werb, and G. Bergers HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion Cancer Cell 13 2008 206 220 (Pubitemid 351318372)
    • (2008) Cancer Cell , vol.13 , Issue.3 , pp. 206-220
    • Du, R.1    Lu, K.V.2    Petritsch, C.3    Liu, P.4    Ganss, R.5    Passegue, E.6    Song, H.7    VandenBerg, S.8    Johnson, R.S.9    Werb, Z.10    Bergers, G.11
  • 99
    • 66149092730 scopus 로고    scopus 로고
    • G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models
    • F. Shojaei, X. Wu, X. Qu, M. Kowanetz, L. Yu, M. Tan, Y.G. Meng, and N. Ferrara G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models Proc. Natl. Acad. Sci. U. S. A. 106 2009 6742 6747
    • (2009) Proc. Natl. Acad. Sci. U. S. A. , vol.106 , pp. 6742-6747
    • Shojaei, F.1    Wu, X.2    Qu, X.3    Kowanetz, M.4    Yu, L.5    Tan, M.6    Meng, Y.G.7    Ferrara, N.8
  • 100
    • 52049091826 scopus 로고    scopus 로고
    • Cellular interactions in the vascular niche: Implications in the regulation of tumor dormancy
    • E. Favaro, A. Amadori, and S. Indraccolo Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy Acta Pathol. Microbiol. Immunol. Scand. 116 2008 648 659
    • (2008) Acta Pathol. Microbiol. Immunol. Scand. , vol.116 , pp. 648-659
    • Favaro, E.1    Amadori, A.2    Indraccolo, S.3
  • 101
    • 70350736093 scopus 로고    scopus 로고
    • The angiogenic switch: Implications in the regulation of tumor dormancy
    • L. Moserle, A. Amadori, and S. Indraccolo The angiogenic switch: implications in the regulation of tumor dormancy Curr. Mol. Med. 9 2009 935 941
    • (2009) Curr. Mol. Med. , vol.9 , pp. 935-941
    • Moserle, L.1    Amadori, A.2    Indraccolo, S.3
  • 102
    • 35548936833 scopus 로고    scopus 로고
    • Models, mechanisms and clinical evidence for cancer dormancy
    • DOI 10.1038/nrc2256, PII NRC2256
    • J.A. Aguirre-Ghiso Models, mechanisms and clinical evidence for cancer dormancy Nat. Rev. Cancer 7 2007 834 846 (Pubitemid 350006258)
    • (2007) Nature Reviews Cancer , vol.7 , Issue.11 , pp. 834-846
    • Aguirre-Ghiso, J.A.1
  • 103
    • 77953362501 scopus 로고    scopus 로고
    • Molecular mechanisms underlying tumor dormancy
    • N. Almog Molecular mechanisms underlying tumor dormancy Cancer Lett. 294 2010 139 146
    • (2010) Cancer Lett. , vol.294 , pp. 139-146
    • Almog, N.1
  • 104
    • 80052867880 scopus 로고    scopus 로고
    • ERK1/2 and p38alpha/beta signaling in tumor cell quiescence: Opportunities to control dormant residual disease
    • M.S. Sosa, A. Avivar-Valderas, P. Bragado, H.C. Wen, and J.A. Aguirre-Ghiso ERK1/2 and p38alpha/beta signaling in tumor cell quiescence: opportunities to control dormant residual disease Clin. Cancer Res. 17 2011 5850 5857
    • (2011) Clin. Cancer Res. , vol.17 , pp. 5850-5857
    • Sosa, M.S.1    Avivar-Valderas, A.2    Bragado, P.3    Wen, H.C.4    Aguirre-Ghiso, J.A.5
  • 105
    • 84875804581 scopus 로고    scopus 로고
    • Regulation of tumor cell dormancy by tissue microenvironments and autophagy
    • M.S. Sosa, P. Bragado, J. Debnath, and J.A. Aguirre-Ghiso Regulation of tumor cell dormancy by tissue microenvironments and autophagy Adv. Exp. Med. Biol. 734 2013 73 89
    • (2013) Adv. Exp. Med. Biol. , vol.734 , pp. 73-89
    • Sosa, M.S.1    Bragado, P.2    Debnath, J.3    Aguirre-Ghiso, J.A.4
  • 106
    • 84874385371 scopus 로고    scopus 로고
    • Cancer stem cells, tumor dormancy, and metastasis
    • P. Patel, and E.I. Chen Cancer stem cells, tumor dormancy, and metastasis Front. Endocrinol. (Lausanne) 3 2012 125
    • (2012) Front. Endocrinol. (Lausanne) , vol.3 , pp. 125
    • Patel, P.1    Chen, E.I.2
  • 107
    • 0028951043 scopus 로고
    • Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
    • L. Holmgren, M.S. O'Reilly, and J. Folkman Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nat. Med. 1 1995 149 153
    • (1995) Nat. Med. , vol.1 , pp. 149-153
    • Holmgren, L.1    O'Reilly, M.S.2    Folkman, J.3
  • 108
    • 0029944122 scopus 로고    scopus 로고
    • Angiostatin induces and sustains dormancy of human primary tumors in mice
    • DOI 10.1038/nm0696-689
    • M.S. O'Reilly, L. Holmgren, C. Chen, and J. Folkman Angiostatin induces and sustains dormancy of human primary tumors in mice Nat. Med. 2 1996 689 692 (Pubitemid 26191958)
    • (1996) Nature Medicine , vol.2 , Issue.6 , pp. 689-692
    • O'Reilly, M.S.1    Holmgren, L.2    Chen, C.3    Folkman, J.4
  • 110
    • 0031038068 scopus 로고    scopus 로고
    • Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis
    • M. Relf, S. LeJeune, P.A. Scott, S. Fox, K. Smith, R. Leek, A. Moghaddam, R. Whitehouse, R. Bicknell, and A.L. Harris Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis Cancer Res. 57 1997 963 969 (Pubitemid 27098025)
    • (1997) Cancer Research , vol.57 , Issue.5 , pp. 963-969
    • Relf, M.1    Lejeune, S.2    Scott, P.A.E.3    Fox, S.4    Smith, K.5    Leek, R.6    Moghaddam, A.7    Whitehouse, R.8    Bicknell, R.9    Harris, A.L.10
  • 111
    • 56749174211 scopus 로고    scopus 로고
    • FLT1 and its ligands VEGFB and PlGF: Drug targets for anti-angiogenic therapy?
    • C. Fischer, M. Mazzone, B. Jonckx, and P. Carmeliet FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat. Rev. Cancer 8 2008 942 956
    • (2008) Nat. Rev. Cancer , vol.8 , pp. 942-956
    • Fischer, C.1    Mazzone, M.2    Jonckx, B.3    Carmeliet, P.4
  • 113
    • 47749109823 scopus 로고    scopus 로고
    • The role of CXC chemokines and their receptors in cancer
    • J. Vandercappellen, J. Van Damme, and S. Struyf The role of CXC chemokines and their receptors in cancer Cancer Lett. 267 2008 226 244
    • (2008) Cancer Lett. , vol.267 , pp. 226-244
    • Vandercappellen, J.1    Van Damme, J.2    Struyf, S.3
  • 114
    • 31544456603 scopus 로고    scopus 로고
    • Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma
    • DOI 10.1309/VPL5-R3JR-7F1D-6V03
    • M.L. Varney, S.L. Johansson, and R.K. Singh Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma Am. J. Clin. Pathol. 125 2006 209 216 (Pubitemid 43167161)
    • (2006) American Journal of Clinical Pathology , vol.125 , Issue.2 , pp. 209-216
    • Varney, M.L.1    Johansson, S.L.2    Singh, R.K.3
  • 115
    • 80053152480 scopus 로고    scopus 로고
    • Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer
    • W.L. Cheng, C.S. Wang, Y.H. Huang, M.M. Tsai, Y. Liang, and K.H. Lin Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer Ann. Oncol. 22 2011 2267 2276
    • (2011) Ann. Oncol. , vol.22 , pp. 2267-2276
    • Cheng, W.L.1    Wang, C.S.2    Huang, Y.H.3    Tsai, M.M.4    Liang, Y.5    Lin, K.H.6
  • 116
    • 33644829930 scopus 로고    scopus 로고
    • An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells
    • P.M. Lacal, F. Ruffini, E. Pagani, and S. D'Atri An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells Int. J. Oncol. 27 2005 1625 1632
    • (2005) Int. J. Oncol. , vol.27 , pp. 1625-1632
    • Lacal, P.M.1    Ruffini, F.2    Pagani, E.3    D'Atri, S.4
  • 117
    • 33744812156 scopus 로고    scopus 로고
    • Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer
    • DOI 10.1016/j.lungcan.2006.02.009, PII S0169500206001735
    • T. Seto, M. Higashiyama, H. Funai, F. Imamura, K. Uematsu, N. Seki, K. Eguchi, T. Yamanaka, and Y. Ichinose Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer Lung Cancer 53 2006 91 96 (Pubitemid 43831360)
    • (2006) Lung Cancer , vol.53 , Issue.1 , pp. 91-96
    • Seto, T.1    Higashiyama, M.2    Funai, H.3    Imamura, F.4    Uematsu, K.5    Seki, N.6    Eguchi, K.7    Yamanaka, T.8    Ichinose, Y.9
  • 122
    • 80051690789 scopus 로고    scopus 로고
    • Brivanib, a dual FGF/VEGF inhibitor, is active both first and second line against mouse pancreatic neuroendocrine tumors developing adaptive/evasive resistance to VEGF inhibition
    • E. Allen, I.B. Walters, and D. Hanahan Brivanib, a dual FGF/VEGF inhibitor, is active both first and second line against mouse pancreatic neuroendocrine tumors developing adaptive/evasive resistance to VEGF inhibition Clin. Cancer Res. 17 2011 5299 5310
    • (2011) Clin. Cancer Res. , vol.17 , pp. 5299-5310
    • Allen, E.1    Walters, I.B.2    Hanahan, D.3
  • 126
    • 84868611960 scopus 로고    scopus 로고
    • Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma
    • J. de Groot, J. Liang, L.Y. Kong, J. Wei, Y. Piao, G. Fuller, W. Qiao, and A.B. Heimberger Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma Oncotarget 3 2012 1036 1048
    • (2012) Oncotarget , vol.3 , pp. 1036-1048
    • De Groot, J.1    Liang, J.2    Kong, L.Y.3    Wei, J.4    Piao, Y.5    Fuller, G.6    Qiao, W.7    Heimberger, A.B.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.